Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.
Open Access
- 1 February 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 179 (2) , 703-708
- https://doi.org/10.1084/jem.179.2.703
Abstract
Interleukin 5 (IL-5) is the main factor that promotes the terminal differentiation of eosinophil progenitors (as indicated by colony formation assays), and enhances the effector capacity of mature eosinophils. IL-5 is produced by T lymphocytes, CD4-/CD8- and mast cells and recently, messenger (m)RNA of this cytokine has been identified in eosinophils from patients with coeliac disease, asthma, or eosinophilic heart diseases. In this study, IL-5 mRNA and immunoreactive IL-5 protein were detected in tissue and blood eosinophils from patients with eosinophilic cystitis or hypereosinophilic syndromes but not in Crohn9s disease. By electron microscopy associated to immunogold staining, immunoreactive IL-5 was identified in eosinophilic granules. After stimulation with IgA-, IgE-, or IgG-immune complexes, blood eosinophils were shown, by immunocytochemistry and by enzyme-linked immunosorbent assay, to secrete IL-5. These observations demonstrate that eosinophils, under physiological stimulation, can release significant amounts of IL-5, which may contribute to local eosinophil recruitment and activation.Keywords
This publication has 15 references indexed in Scilit:
- Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases.1993
- Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophoreEuropean Journal of Immunology, 1993
- Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.Journal of Clinical Investigation, 1992
- Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.The Journal of Experimental Medicine, 1992
- Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activationJournal of Allergy and Clinical Immunology, 1991
- Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.The Journal of Experimental Medicine, 1991
- Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses.The Journal of Experimental Medicine, 1991
- Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytesGastroenterology, 1989
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Heterogeneity of Human Peripheral Blood Eosinophils: Variability in Cell Density and Cytotoxic Ability in Relation to the Level and the Origin of HypereosinophiliaInternational Archives of Allergy and Immunology, 1983